These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3556394)

  • 41. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum.
    Nabeshima T; Yamaguchi K; Yamada K; Hiramatsu M; Furukawa H; Kameyama T
    Eur J Pharmacol; 1983 Sep; 93(3-4):229-34. PubMed ID: 6416871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.
    Heal DJ; Philpot J; Molyneux SG; Metz A
    Neuropharmacology; 1985 Dec; 24(12):1201-5. PubMed ID: 4094656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral effects of chronic phencyclidine administration in rats.
    Sturgeon RD; Fessler RG; London SF; Meltzer HY
    Psychopharmacology (Berl); 1982; 76(1):52-6. PubMed ID: 6805009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A; Ramarao P; Bhargava HN
    Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic phenytoin and the stereotyped motor response induced by 5-methoxy-N,N-dimethyltryptamine in rats.
    Lalonde R; Botez MI
    Brain Res; 1985 Feb; 326(2):388-91. PubMed ID: 4038621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of MK-801 on body temperature and behavior in the rat: cross-sensitization and cross-tolerance with phencyclidine.
    Pechnick RN; Hiramatsu M
    Eur J Pharmacol; 1994 Jan; 252(1):35-42. PubMed ID: 8149994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The administration of baclofen to mice increases 5-HT2-mediated head-twitch behaviour and 5-HT2 receptor number in frontal cortex.
    Metz A; Goodwin GM; Green AR
    Neuropharmacology; 1985 Apr; 24(4):357-60. PubMed ID: 4000408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and chronic phencyclidine administration effects on the conversion of 3H-tryptophan to 3H-serotonin in rat forebrain.
    Johnson KM
    J Neural Transm; 1982; 53(2-3):179-86. PubMed ID: 7077314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal hemodynamic responses to 5-hydroxytryptamine (5-HT): involvement of the 5-HT receptor subtypes in the canine kidney.
    Shoji T; Tamaki T; Fukui K; Iwao H; Abe Y
    Eur J Pharmacol; 1989 Nov; 171(2-3):219-28. PubMed ID: 2576001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine.
    Balsara JJ; Bapat TR; Nandal NV; Gada VP; Chandorkar AG
    Psychopharmacology (Berl); 1986; 88(3):275-8. PubMed ID: 2938207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.